A.B.
Senior Member
- Messages
- 3,780
Very nice. I'm especially pleased to see Lipkin getting everything he needs to do the full study.
Maureen R. Hanson is Liberty Hyde Bailey Professor in the Department of Molecular Biology & Genetics. She received a B.S. degree at Duke University and a Ph.D. in Cell and Developmental Biology from Harvard University. After completing an NIH postdoctoral fellowship at Harvard, she joined the faculty of the Biology Department at University of Virginia. She moved to Cornell as Associate Professor and was promoted to Professor in 1991.
Yes, odd combo indeed:Bit of an odd combo of topics. I wonder if this is another case of a scientist having a loved one who is sick and deciding to apply their skills in a new area.
Dr. Hanson has two different research programs, related through their dependence on modern methods for examining genome sequences and gene expression. Her research in plant biology has always focused on the genome-containing organelles of plants, chloroplasts and mitochondria.
A second research area is the pathophysiology of the human illness Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis. Individuals with this illness often have gastrointestinal issues and evidence of immune system activation and dysfunction. One current project involves characterization of the gut and blood microbiome in healthy vs. ill subjects. Another project aims to identify differences in gene expression at baseline and following exercise in healthy and in subjects diagnosed with CFS/ME.
sorry extra stupid today (this excitement doesn't help - squee) . . . what is MDP?@aimossy Great news!
Can the MDP pass on our congratulations and best wishes to Drs Hornig and Lipkin and the team at CII?
sorry extra stupid today (this excitement doesn't help - squee) . . . what is MDP?
This is great news. As for "chump change," ask any biomed lab researcher if they'd like $760,000 from NIH. Lipkin now has $1.5 million, about half from crowdfunding and half from NIH, to do a thorough study, and he'll be using the samples collected during the XMRV search a few years ago. This is a very wise thing to do - leverage this biobank. When Dr. Collins wrote to me a few weeks ago, he mentioned the biobank as a resource and implied it would be used again.
We need to continue to demand much more.
I know she worked w/ Bell before his retirement. He thinks she is top notch. We are lucky to have her working on this plague.Re Maureen Hanson (Cornell)
Yes, odd combo indeed:
If anyone has not signed the funding parity petitions here is the link to MEAction's page and petition.Agreed.
Klimas: "Genomic approach to find novel biomarkers and mechanisms of CFS/ME"
National Institute of Neurological Disorders and Stroke
$320,000
Such great news. All three look like promising studies to me. We must thank people involved, especially the decision makers. Hope someone knows who we need to be thanking?
Also perhaps thanks should go to the grant applicants/ reciprocants for taking the time to apply and doing the work on our behalf.Disturbing video!
Great idea about thanking. What about thanking Vicky Whittemore? Or saying to her that we don't know who to thank and would like her to pass on our thanks? It would be a nice way of welcoming her to her new job - I was impressed by her attitude at CFSAC.
Also perhaps thanks should go to the grant applicants/ reciprocants for taking the time to apply and doing the work on our behalf.
Great news! I'm especially pleased to see Lipkin finally getting some funding.
Also perhaps thanks should go to the grant applicants/ reciprocants for taking the time to apply and doing the work on our behalf.
With all the fuss around the recent application denials, NIH would have to be extraordinarily deaf to turn him down again.
I do see this as a sign the pressure on NIH is starting to bite. Now is the time to double down and keep after them until we have funding commensurate with disease burden.
does this mean they've got all the money they need- no need for more donations?